EUVIMEDEUVIMED entdecken
Crossref

Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation

Lun Gao, Xiongfei Jing, Qiuwei Hua, Zhiyang Li, Pan Lei, Ping Song, Long Zhou, Yihao Tian, Junhui Liu, Qiang Cai

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Lun Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China; Central Laboratory, Renmin Hospital of Wuhan Universi…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Biomarkers, Tumor, Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma is the most common malignant tumor of the central nervous system, and the ability of traditional clinical treatment to prolong the survival of glioma patients is limited. A substantial body of evidence underscores the pivotal role of the immune system in eradicating malignant cells and impeding tumor metastasis. Consequently, tumor immunotherapy has become a promising avenue to address the clinical conundrum faced by glioma patients. The complement system is a natural immune system that is an important line of defense in the immune response. C1S plays a key role in activating the classical complement system. Nevertheless, few studies have focused on the role of C1S in glioma tumorigenesis and progression. In this study, we demonstrated that C1S was upregulated in GBM (Grade IV) and low-grade gliomas (LGG, Grade II-III) by combining glioma cohorts from multiple public databases with our internal independent cohorts and that increased C1S expression levels predict a poor prognosis for gliomas. Cox regression analysis identified C1S as an important prognostic indicator for glioma patients. In addition, gene functional enrichment analysis demonstrated that C1S was involved in cellular immunity, T-cell activation, macrophage differentiation, and cell proliferation. Further experiments demonstrated that C1S facilitates tumor cell proliferation, cell migration and intracranial tumor growth in nude mice. More importantly, we evaluated the role of C1S in immune infiltration. These results suggested that C1S was closely related to a variety of immune cell types in glioma, especially M2 macrophages. Our findings were further validated via glioma tissue microarray immunohistochemical analysis and an M2 macrophage infiltration assay. Together, these findings revealed the underlying critical role of C1S in glioma tumorigenesis, progression, and the tumor immune microenvironment, contributing to further understanding of glioma pathogenesis and guiding immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsBiomarkers, TumorMacrophagesAnimalsHumansPrognosisCell Line, TumorMiceMice, NudeComputational BiologyCell MovementMaleCell ProliferationGene Expression Regulation, NeoplasticFemale

Stichwörter der Autor:innen

C1SGliomasIntracranial xenograft modelM2 macrophagePrognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China; Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China.
  • Department of Neurosurgery, Xiantao First People's Hospital Affiliated to Yangtze University, Xiantao City 433000, PR China.
  • Department of Human Anatomy, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei 430071, PR China. Electronic address: yihaotian@whu.edu.cn.
  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China; Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China. Electronic address: doctorhsdqe@whu…
  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China; Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China. Electronic address: caiqno@whu.edu.…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gao, L., Jing, X., Hua, Q., Li, Z., Lei, P., Song, P., Zhou, L., Tian, Y., Liu, J., & Cai, Q. (2024). Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113573

Vancouver

Gao L, Jing X, Hua Q, Li Z, Lei P, Song P, et al. Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113573

BibTeX
@article{Gao2024,
  author = {Gao, Lun and Jing, Xiongfei and Hua, Qiuwei and Li, Zhiyang and Lei, Pan and Song, Ping and Zhou, Long and Tian, Yihao and Liu, Junhui and Cai, Qiang},
  title = {Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113573}
}
Kostenlos starten →